VALNEVA |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.448 EUR | +4.68% |
|
+9.74% | -27.40% |
| 06-28 | Valneva's Chikungunya Vaccine Secures Approval for Use in EU | MT |
| 06-26 | Valneva SE Appoints Daniele Guyot-Caparros as Board of Directors | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| VALNEVA | Other Biotechnology & Medical Research | +4.68% | +9.74% | -27.40% | -48.96% | +11.41% | 475M | - | - | - |
Technical Rankings Surperformance
- Stock Market
- Equities
- VLA Stock
- AYJ Stock
- Charts Valneva
- Comparison Chart
